Results 41 to 50 of about 503 (171)
Developmental Medicine &Child Neurology, Volume 67, Issue 8, Page 1004-1025, August 2025.Why does infantile epileptic spasms syndrome (IESS) occur with a variety of underlying conditions and why does it respond to adrenocorticotrophin hormone (ACTH)/corticosteroids? Our scoping review summarizes five hypotheses from the literature: gene/epigenetic regulation, stress/HPA axis activation, neuroinflammation/immune function, altered neuronal ...
Emily A. Innes +6 more
wiley +1 more source
Diagnostic Importance of Cutaneous Manifestations of Neurofibromatosis—A Systematic Review
Neurology and Clinical Neuroscience, Volume 13, Issue 3, Page 165-173, May 2025.ABSTRACT A class of hereditary diseases known as neurofibromatoses results in tumor growth on tissue from nerves. The spinal cord, nerves, and brain are among the parts of the nervous framework where these tumors can form. Similar to other genetic disorders, neurofibromatosis discloses complicated phenotypes, exhibiting varying benign and malignant ...
Hina Aslam +11 more
wiley +1 more source
Problèmes d'apprentissage scolaire et neurofibromatose 1
Glossa, 1996 Jacques Zeller, Pierre Wolkenstein
doaj +1 more source
Developmental Medicine &Child Neurology, Volume 67, Issue 4, Page 537-549, April 2025.Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16157 In this double‐blind, placebo‐controlled, randomized clinical trial, 31 adolescents with neurofibromatosis type 1 (NF1) were enrolled to test the effects of lamotrigine on cognitive functioning.
Myrthe J. Ottenhoff +21 more
wiley +1 more source
Une tumeur maligne des gaines des nerfs périphériques compliquant la maladie de Von Recklinghausen
The Pan African Medical Journal, 2015 Les tumeurs malignes des gaines des nerfs périphériques ou MPNST (Malign Peripheral Nerve Sheath Tumors selon les anglo-saxons) sont des tumeurs rares qui constituent la principale complication des neurofibromatoses de type 1 (NF1) à l'âge adulte.
Tilila Hajjad +3 more
doaj +1 more source
Transformation sarcomateuse de la maladie de Recklinghausen
The Pan African Medical Journal, 2021 La neurofibromatose type I est une maladie génétique fréquente. Les patients qui en sont atteints ont 4 fois plus de risque de développer une pathologie tumorale. La majorité des tumeurs sont bénignes (neurofibromes), même si les complications tumorales
Younes Barbach, Fatima Zahra Mernissi
doaj +1 more source
An Unexplored Diversity for Adaptation of Germination to High Temperatures in Brassica Species
Evolutionary Applications, Volume 18, Issue 3, March 2025.ABSTRACT Elevated temperatures inhibit the germination of a concerning number of crop species. One strategy to mitigate the impact of warming temperatures is to identify and introgress adaptive genes into elite germplasm. Diversity must be sought in wild populations, coupled with an understanding of the complex pattern of adaptation across a broad ...
M. Tiret +10 more
wiley +1 more source
Anais Brasileiros de Dermatologia, 2013 Neurofibromatosis, which was first described in 1882 by Von Recklinghausen, is a genetic disease characterized by a neuroectodermal abnormality and by clinical manifestations of systemic and progressive involvement which mainly affect the skin, nervous ...
João Roberto Antônio +2 more
doaj
Jejunal stromal tumor and neurofibromatosis
Journal of Coloproctology, 2019 Gastrointestinal stromal tumors, although rare, are the most common primary mesenchymal neoplasms of the gastrointestinal tract and originate from the interstitial cells of Cajal.
Daniela Fonseca Lisboa Kayser +5 more
doaj +1 more source
Skin Research and Technology, Volume 30, Issue 9, September 2024.Abstract Background Cutaneous neurofibromas (cNFs) are a major cause of disfigurement in patients with Neurofibromatosis Type 1 (NF1). However, clinical trials investigating cNF treatments lack standardised outcome measures to objectively evaluate changes in cNF size and appearance.
Jonathan C. L. Lau +12 more
wiley +1 more source